Author:
Velentzis Louiza S.,Salagame Usha,Canfell Karen
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Board of the International Menopause Society, Pines A, Sturdee DW, Birkhäuser MH, Schneider HP, Gambacciani M, Panay N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric. 2007;10:181–94.
2. Daly E, Roche M, Barlow D, Gray A, McPherson K, Vessey M. MHT: an analysis of benefits, risks and costs. Br Med Bull. 1992;48:368–400.
3. Cheung AP, Wren BG. A cost-effectiveness analysis of hormone replacement therapy in the menopause. MJA. 1992;156:312–6.
4. Weinstein MC. Estrogen Use in Postmenopausal Women — Costs, Risks, and Benefits. N Engl J Med. 1980;303:308–16.
5. UK Medicines and Healthcare products Regulatory Agency (UKMHRA). Drug Safety Update September 2007, vol 1 issue 2: 2. http://www.mhra.gov.uk/home/groups/s-par/documents/websiteresources/con2032228.pdf . Accessed 30 May 2016.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献